publication date: Dec. 19, 2010

In this issue: 

Remarks on HPV vaccines, SPORE funds create controversy for NCI’s John Niederhuber.

NCI official says he hopes to “put more money” into SPOREs.

AACR Meeting: Celebrex studies show benign polyp reduction, point to challenges in biomarker validation.

Advocacy: NCCS, ASCO petition FDA to set standards for expanded access programs.

Download (PDF 1.9MB)

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.